Accurately and with fast iterations
The ability to characterize, analyze, and test the product is crucial when developing inhaled medicines. To arrive at a perfect product, you need to develop it in several iterations. Without the ability to analyze the product accurately and with fast iterations, you will either fail or be too slow in your development efforts.
Iconovo has well-equipped state-of-the-art analytical laboratories, and a competent group of analytical scientists working in cross-functional teams during product development. We have a range of test methodologies required to support the development of inhaled medicines. Our team has experience from working with small molecules as well as biologics.
Iconovo has the capacity for:
- Characterization of all relevant solid-state aspects of dry powders, crucial in all phases from pre-formulation to formulation optimization
- Aerosol characterization using Cascade impaction, Delivered dose analysis, and HPLC
- Dissolution profiling and lung dose prediction utilizing anatomical throat or nasal models combined with patient inhalation profiles
- In vivo prediction via advanced in vitro models
- Analytical method development and a set of climate chambers to enable technical stability studies
- Device Verification Material
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
Interim CEO
Anders Månsson
Mail: anders.mansson@iconovo.se
Press releases
Follow us on Linkedin
